Let's Make things Better
JNS: AstraZeneca has admitted in court documents that its COVID-19 vaccine, developed with the University of Oxford, can lead to a rare side effect known as thrombosis with thrombocytopenia syndrome …
AstraZeneca admits COVID-19 vaccine can cause rare side effects Read More
लेखक- आशीष सिन्हा, वरिष्ठ पत्रकार। # आपदा में भी हौसले की प्रेरणा देती है आशीष की नई पुस्तक अपनी पुस्तक की शुरुआत उन्होंने कोविड-19 के बारे में छोटी से झलक …
पुस्तक समीक्षा: “कोविड-19 महामारी से हमने जो सबक सीखा” Read More
New Delhi: The World Health Organization (WHO) has given its endorsement to a cost-effective and highly efficient malaria vaccine developed through collaboration between the Pune-based Serum Institute of India (SII) …
WHO approves world’s 2nd malaria vaccine; cheaper & easier to produce Read More
JNS: iNCOVACC— nasal vaccine against Covid-19 would be available in the market for the public from the fourth week of January. Bharat Biotech, Hyderabad-based Biotechnology Company said that the vaccine …
Intranasal Covid-19 vaccine, ‘iNCOVACC’ @ Rs 800 from January 23 Read More
JNS: The intranasal Covid-19 vaccine— iNCOVACC (BBV154), developed by Bharat Biotech, received approval from the ministry of health on Friday to be added to the vaccination programme as a booster …
iNCOVACC – Nasal spray vaccine gets nod as booster shot in adults Read More
JNS: WHO warns of an urgent threat of measles spreading globally due to COVID-19’s drop in vaccination coverage and poor disease surveillance. Nearly 40 million children missed a measles vaccine injection …
Around 40 million kids skipped measles vaccine last year due to COVID pandemic: WHO Read More
चंद्रपुरा । डीवीसी चंद्रपुरा के मुख्य अभियंता एवं परियोजना प्रधान अजय कुमार दत्ता के निर्देश पर डीवीसी चंद्रपुरा के स्थानीय प्रबंधन के सहयोग से झारखंड सरकार के स्वास्थ्य विभाग के …
चंद्रपुरा में लगाया गया कोरोना वैक्सीन का 180 बूस्टर डोज Read More
JNS: Government has decided to make precaution doses of COVID vaccines available to the above 18 population group from tomorrow at private vaccination centres. “All those who are more than …
COVID vaccine precaution dose for all above 18 years Read More
JNS: Amidst rising COVID cases in European and few Asian countries, the National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap between the first and second dose of …
“Reduce Covishield vaccine gap” : NTAGI Read More
JNS: Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation to COVID-19 vaccine Corbevax for children between 12-18 years of age group. With the emergency use approval to Corbevax, …
DCGI grants EUA to Corbevax for children between 12-18 years Read More